發(fā)布時間：2018-09-04 07:16

【摘要】： 協(xié)同刺激分子(co-stimulatory molecules)在免疫調(diào)節(jié)中起著重要的作用,B7-H3是新近發(fā)現(xiàn)的協(xié)同刺激分子家族成員。人B7-H3有兩種不同形式的剪切體:B7-H3a和B7-H3b。B7-H3a胞外段由IgV-IgC兩個免疫球蛋白結(jié)構(gòu)域組成,故又稱為2IgB7-H3,而B7-H3b胞外段由IgV1-IgC1-IgV2-IgC2四個免疫球蛋白結(jié)構(gòu)域組成,故又稱為4IgB7-H3。B7-H3mRNA表達(dá)水平極其廣泛,在幾乎所有淋巴組織及非淋巴組織均能檢測到該分子mRNA的轉(zhuǎn)錄,其中4IgB7-H3mRNA表達(dá)豐度遠(yuǎn)高于2IgB7-H3mRNA,因此,既往的研究均認(rèn)為4IgB7-H3是B7-H3的主要表達(dá)形式。但由于沒有特異性識別人4IgB7-H3的單克隆抗體,所以無法明確4IgB7-H3在組織中的蛋白表達(dá)譜。本研究制備了一株可以特異性識別人4IgB7-H3的鼠源性抗人B7-H3單克隆抗體,繼而研究和分析了該分子的表達(dá)譜。 目的:研制特異性識別鼠抗人4IgB7-H3單克隆抗體并對其進(jìn)行了初步應(yīng)用。 方法:以高表達(dá)人4IgB7-H3的293T細(xì)胞為免疫原,常規(guī)免疫小鼠、細(xì)胞融合和篩選。L929/4IgB7-H3基因轉(zhuǎn)染細(xì)胞為抗體篩選陽性細(xì)胞,L929/2IgB7-H3基因轉(zhuǎn)染細(xì)胞為抗體篩選陰性細(xì)胞,經(jīng)間接免疫熒光標(biāo)記和流式細(xì)胞術(shù)對雜交瘤細(xì)胞進(jìn)行反復(fù)篩選和多次亞克隆化,流式細(xì)胞術(shù)分析抗體對B7家族不同成員基因轉(zhuǎn)染細(xì)胞的識別。經(jīng)位點(diǎn)競爭實(shí)驗(yàn)對該抗體抗原表位的識別特異性進(jìn)行了鑒定。利用兩株抗體采用流式細(xì)胞術(shù)檢測4IgB7-H3在腫瘤細(xì)胞株和免疫細(xì)胞上的表達(dá)特性以及免疫組織化學(xué)方法檢測此兩株抗體在腫瘤細(xì)胞株和腫瘤組織上的識別情況。 結(jié)果:成功地制備了兩株持續(xù)穩(wěn)定分泌鼠抗人B7-H3單克隆抗體的雜交瘤細(xì)胞株4C3和9C3,其中單抗4C3既能識別2IgB7-H3又能識別4IgB7-H3分子,而單抗9C3只能識別4IgB7-H3。蛋白水平上4IgB7-H3相當(dāng)局限地表達(dá)在一些腫瘤細(xì)胞株、人外周血單核細(xì)胞以及成熟的樹突狀細(xì)胞;而B7-H3(2IgB7-H3和/或4IgB7-H3)分子廣泛地表達(dá)在多種腫瘤細(xì)胞株、單核細(xì)胞以及樹突狀細(xì)胞。此外,免疫組織化學(xué)分析表明4IgB7-H3可在腦膠質(zhì)瘤組織中特異性表達(dá),并隨著膠質(zhì)瘤病理分級的升高而遞增。 結(jié)論:獲得了兩株穩(wěn)定分泌鼠抗人B7-H3單克隆抗體的雜交瘤細(xì)胞株4C3和9C3。4IgB7-H3單克隆抗體9C3的成功獲得為進(jìn)一步分析人B7-H3兩種剪切體的表達(dá)特性以及生物學(xué)功能提供了物質(zhì)基礎(chǔ)。
[Abstract]:Costimulator (co-stimulatory molecules) plays an important role in immunomodulation. B7-H3 is a newly discovered member of costimulator family. Human B7-H3 has two different forms of shearing bodies: B7-H3a and B7-H3b.B7-H3a, which are composed of two immunoglobulin domains (IgV-IgC), so they are also called 2IgB7-H3. The extracellular segments of B7-H3b are composed of four immunoglobulin domains (IgV1-IgC1-IgV2-IgC2), so they are also called 4IgB7-H3.B7-H3mRNA. The transcription of mRNA was detected in almost all lymphoid tissues and non-lymphoid tissues, in which the abundance of 4IgB7-H3mRNA expression was much higher than that of 2IgB7-H3mRNAs. Therefore, previous studies have suggested that 4IgB7-H3 is the main expression form of B7-H3. However, there is no specific monoclonal antibody to recognize human 4IgB7-H3, so it is impossible to identify the protein expression profile of 4IgB7-H3 in tissues. In this study, a murine monoclonal antibody against human 4IgB7-H3 was prepared and its expression profile was analyzed. Objective: to develop a specific mouse anti-human 4IgB7-H3 monoclonal antibody and its preliminary application. Methods: 293T cells with high expression of human 4IgB7-H3 were used as immunogen, and mice were immunized by routine immunization. The cells transfected with. L929 / 4IgB7-H3 gene were used as antibody screening positive cells. L929 / 2 IgB7-H3 gene transfected cells were used as antibody screening negative cells. The hybridoma cells were screened repeatedly by indirect immunofluorescence and flow cytometry. The recognition of different members of B7 gene transfection cells was analyzed by flow cytometry. The recognition specificity of the antigen epitope was identified by site competition test. The expression of 4IgB7-H3 in tumor cell lines and immune cells was detected by flow cytometry and the recognition of these two antibodies in tumor cell lines and tumor tissues was detected by immunohistochemical method. Results: two hybridoma cell lines, 4C3 and 9C3, which secreted murine monoclonal antibody against human B7-H3 successfully, were successfully prepared. McAb 4C3 could recognize both 2IgB7-H3 and 4IgB7-H3 molecules, while McAb 9C3 could recognize only 4IgB7-H3. At the protein level, 4IgB7-H3 is expressed in some tumor cell lines, human peripheral blood monocytes and mature dendritic cells, while B7-H3 (2IgB7-H3 and / or 4IgB7-H3) molecules are widely expressed in many tumor cell lines, monocytes and dendritic cells. In addition, immunohistochemical analysis showed that 4IgB7-H3 could be expressed specifically in gliomas and increased with the increase of glioma pathological grade. Conclusion: two hybridoma cell lines, 4C3 and 9C3.4IgB7-H3 monoclonal antibody 9C3, which secrete murine anti-human B7-H3 monoclonal antibody stably, have been successfully obtained, which provide a material basis for further analysis of the expression characteristics and biological functions of human B7-H3.
【學(xué)位授予單位】：蘇州大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2009
【分類號】：R392

【相似文獻(xiàn)】

相關(guān)會議論文 前2條

1 周迎會;馬震宇;陳永井;馬珍妮;王勤;王雪峰;馬泓冰;謝芳;張學(xué)光;;人4IgB7-H3-Fc融合蛋白的制備及其對T細(xì)胞的共刺激作用[A];中國免疫學(xué)會第五屆全國代表大會暨學(xué)術(shù)會議論文摘要[C];2006年

2 馬震宇;周迎會;陳永井;張光波;費(fèi)敏;謝芳;王雪峰;王勤;馬珍妮;張學(xué)光;;轉(zhuǎn)染人4IgB7-H3細(xì)胞株對T細(xì)胞的促增殖作用[A];中國免疫學(xué)會第五屆全國代表大會暨學(xué)術(shù)會議論文摘要[C];2006年

相關(guān)碩士學(xué)位論文 前2條

1 何娜;鼠抗人4IgB7-H3單克隆抗體的研制及其初步應(yīng)用[D];蘇州大學(xué);2009年

2 唐春花;人共刺激分子4IgB7-H3與人β1，，3半乳糖基轉(zhuǎn)移酶7相互關(guān)系初探[D];蘇州大學(xué);2008年

本文編號：2221377